MAKETA 5/3
MAKETA 5/3
MAKETA 5/3
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
8<br />
A C T A M E D I C A M A R T I N I A N A 2 0 0 5 5/3<br />
15. Liekens S, De Clerq E, Neyts J. Angiogenesis: regulators and clinical applications. Biochemical Pharmacology 2001;<br />
61: 253-270<br />
16. Tonini T, Rossi F, Claudio PP.Molecular basis of angiogenesis and Cancer. Oncogene 2003; 22: 6549-6556<br />
17. Nor JE, Polverini PJ. Role of endothelial cell survival and death signals in angiogenesis. Angiogenesis 1999; 3: 101-<br />
106<br />
18. Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 1995;<br />
36:127-137<br />
19. Mecklenburg L, Tobin DJ, Muller-Rover S et al. Active hair growth (anagen) is associated with angiogenesis. J Invest<br />
Dermatol 2000; 114: 909-916<br />
20. Hubler WR, Wolf JE. Melanoma, tumor angiogenesis and human Neoplasia. Cancer 1976; 38: 187-192<br />
21. Pepper MS, Ferrara N, Orci L et al. Potent synergism between vascular endothelial growth factor and basic fibroblast<br />
growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res 1992; 189: 824-831<br />
22. Hannah D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell<br />
1996; 86: 353-364<br />
23. Marcoval J, Moreno A, Graelis J et al. Angiogenesis and malignant melanoma – angiogenesis is related to the development<br />
of vertical tumorigenic phase. J Cutan Pathol 1997; 24: 212-218<br />
24. Kashani-Sabet M, Sagebiel RW, Ferreira CMM et al. Tumor vascularity in the prognostic assessment of primary cutaneous<br />
melanoma. J Clin Oncol 2Q002, 20 (7): 1826-1831<br />
25. Jonjic N, Zamolo G, Stifter S et al. Cytomorphological variations, proliferation and angiogenesis in the prognosis of<br />
cutaneous melanoma. Clin and Exp Dermatol 2003; 28: 310-314<br />
26. Straume O, Salvesen HB, Akslen LA. Angiogenesis is important in vertical growth phase melanomas. Intern J Oncol<br />
1999; 15: 595-599<br />
27. Neitzel LT, Neitzel CD, Magee KL et al. Angiogenesis correlates with metastasis in melanoma. Ann Surg Oncol 1999;<br />
6 (1): 70-74<br />
28. Urgurel S, Rappl G, Tilgen W, Reinhold U. Increased serum concentration of angiogenic factors in malignant<br />
melanoma patients correlates with tumor progression and survival. J Clin Oncol 2001;19 (2): 577-583<br />
29. Staibano S, Boscaino A, Salvatore G et al. The prognostic significance of tumor angiogenesis in nonaggressive and<br />
aggressive basal cell carcinoma of the human skin. Hum Pathol 1996; 27 (7): 695-700<br />
30. Razon MJ, Kraling BM, MullikenJB at al. Increased apoptosis coincides with onset of involution in infantile hemangioma.<br />
Microcirculation 1998; 5: 189-195<br />
31. Boye E, Yu Y, Paranya G et al. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest<br />
2001; 107: 745-752<br />
32. Beck L, D’Amore PA. Vascular development: cellular and molecular regulation. FASEB J 1997; 11 (5): 365-373<br />
33. Dosquet C, Coudert MC, Wassef M et al. Importance of bFGF for diagnosis and treatment of hemangiomas. Ann Dermatol<br />
Venereol 1998; 125(5): 313-316<br />
34. Barker JNWN. Pathophysiology of psoriasis. Lancet 1991; 338:227-230<br />
35. Braverman IM, Yen A. Ultrastructure of the capillary loops in the dermal papillae of psoriasis. J Invest Dermatol<br />
1977; 68: 53-60<br />
36. Braverman IM, Simbley BA. Role of microcirculation in the treatment and pathogenesis of psoriasis. J Invest Dermatol<br />
1982; 78: 12 -17<br />
37. Creamer D, Sullivan D, Bicknell R et al. Angiogenesis in psoriasis. Angiogenesis 2002; 5: 231-236<br />
38. Bushan M, McLaughlin B, Weiss JB et al. Levels of endothelial cell - stimulating angiogenesis factor and VEGF are<br />
elevated in psoriatic epidermis. Br J Dermatol 1999; 141: 1054-1060<br />
39. Creamer D, Allen M, Sousa A at al. Altered vascular endothelium integrin expression in psoriasis. Am J Pathol<br />
1995; 147: 1661-1667<br />
40. Kuroda K, Sapadi A, Shoji T et al. Altered expression of angiopoetins and Tie 2 receptor in psoriasis. J Invest Dermatol<br />
2001; 116:713-720<br />
41. Rosen L. Antiangiogenic Strategies and agents in clinical trials. The Oncologist 2005; 5: 20-27<br />
Received: August, 8, 2005<br />
Accepted: November, 2, 2005